x

Aquestive Therapeutics, Inc. (Nasdaq:AQST)

Health Care/Life Sciences • Pharmaceuticals
CIK 1398733
Company

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Address
30 Technology Drive
Warren, New Jersey 07059
Employees
135
Stock Info
Close
$2.7900
Day Range
2.7300 - 2.8495
52 Week Range
2.2400 - 6.2300
Average volume
1.69M
Short Interest
9.98M (02/14/25)
% of Float Shorted
12.36%
Market Cap
$254.39M
Revenue
$50.58M
Net Income
-$7.87M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.4492
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Independent Director
Julie Krop
Vice Chairman
John S. Cochran
Independent Director
Abigail L. Jenkins
Independent Director
Marco Taglietti
Independent Director
Timothy E. Morris
SEC filings
DateFormEvent
19 Dec, 2024 8-K
4 Dec, 2024 4
2 Dec, 2024 8-K
27 Nov, 2024 4
14 Nov, 2024 SC 13G/A
8 Nov, 2024 SC 13G
7 Nov, 2024 8-K
6 Nov, 2024 8-K
4 Nov, 2024 8-K
4 Nov, 2024 10-Q
25 Oct, 2024 8-K
24 Oct, 2024 8-K
22 Oct, 2024 SC 13G
16 Oct, 2024 8-K
2 Oct, 2024 4/A
2 Oct, 2024 4/A
2 Oct, 2024 4/A
2 Oct, 2024 4/A
27 Sep, 2024 8-K
9 Sep, 2024 8-K
14 Aug, 2024 8-K
12 Aug, 2024 4
6 Aug, 2024 10-Q
6 Aug, 2024 8-K
25 Jul, 2024 8-K
21 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 4
21 Jun, 2024 8-K
21 Jun, 2024 4
21 Jun, 2024 4
12 Jun, 2024 3/A
11 Jun, 2024 3
11 Jun, 2024 4
7 Jun, 2024 8-K
6 Jun, 2024 8-K
13 May, 2024 4
13 May, 2024 4
8 May, 2024 8-K
7 May, 2024 8-K
7 May, 2024 10-Q
29 Apr, 2024 8-K
26 Apr, 2024 DEFA14A
26 Apr, 2024 3
26 Apr, 2024 ARS
26 Apr, 2024 DEF 14A
24 Apr, 2024 424B2
24 Apr, 2024 424B2
23 Apr, 2024 EFFECT
22 Apr, 2024 8-K
19 Apr, 2024 CORRESP
19 Apr, 2024 CORRESP
16 Apr, 2024 CORRESP
8 Apr, 2024 UPLOAD
3 Apr, 2024 S-3
1 Apr, 2024 8-K
1 Apr, 2024 SC 13G
21 Mar, 2024 424B5
21 Mar, 2024 8-K
19 Mar, 2024 424B5
19 Mar, 2024 4
15 Mar, 2024 144
15 Mar, 2024 8-K
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
12 Mar, 2024 4
11 Mar, 2024 4
11 Mar, 2024 4
11 Mar, 2024 4
11 Mar, 2024 4
11 Mar, 2024 4
11 Mar, 2024 4
11 Mar, 2024 4
11 Mar, 2024 4
8 Mar, 2024 144
5 Mar, 2024 10-K
5 Mar, 2024 8-K
14 Feb, 2024 SC 13G
12 Feb, 2024 S-8
8 Dec, 2023 8-K
5 Dec, 2023 8-K
8 Nov, 2023 8-K
6 Nov, 2023 10-Q
6 Nov, 2023 8-K
2 Nov, 2023 8-K
10 Oct, 2023 8-K
2 Oct, 2023 424B3
29 Sep, 2023 EFFECT
27 Sep, 2023 CORRESP
25 Sep, 2023 UPLOAD
21 Sep, 2023 S-3
20 Sep, 2023 8-K
11 Aug, 2023 8-K
9 Aug, 2023 4
9 Aug, 2023 4
9 Aug, 2023 4
9 Aug, 2023 4
9 Aug, 2023 S-8
9 Aug, 2023 4
9 Aug, 2023 4
9 Aug, 2023 4
9 Aug, 2023 4
9 Aug, 2023 4
7 Aug, 2023 8-K
7 Aug, 2023 10-Q
2 Aug, 2023 8-K
27 Jul, 2023 8-K
30 Jun, 2023 3
29 Jun, 2023 8-K
23 Jun, 2023 4
23 Jun, 2023 8-K
23 Jun, 2023 4
23 Jun, 2023 4
23 Jun, 2023 4
23 Jun, 2023 4
23 Jun, 2023 4
31 May, 2023 8-K
5 May, 2023 4
5 May, 2023 4
5 May, 2023 4
5 May, 2023 4
5 May, 2023 4
5 May, 2023 4
5 May, 2023 4
5 May, 2023 4
2 May, 2023 ARS
2 May, 2023 10-Q
2 May, 2023 8-K
28 Apr, 2023 DEF 14A
28 Apr, 2023 DEFA14A
18 Apr, 2023 PRE 14A
13 Apr, 2023 8-K
31 Mar, 2023 10-K
13 Mar, 2023 8-K
9 Mar, 2023 4
9 Mar, 2023 4
9 Mar, 2023 4
9 Mar, 2023 4
9 Mar, 2023 4
9 Mar, 2023 4
9 Mar, 2023 4
9 Mar, 2023 4
7 Mar, 2023 8-K
7 Mar, 2023 8-K
6 Mar, 2023 8-K
7 Feb, 2023 8-K
24 Jan, 2023 8-K
18 Jan, 2023 S-8
11 Jan, 2023 3
11 Jan, 2023 3
3 Jan, 2023 8-K
22 Dec, 2022 8-K
20 Dec, 2022 8-K
8 Nov, 2022 4
8 Nov, 2022 4
8 Nov, 2022 4
8 Nov, 2022 4
8 Nov, 2022 4
7 Nov, 2022 8-K
2 Nov, 2022 8-K
1 Nov, 2022 10-Q
1 Nov, 2022 8-K
27 Oct, 2022 8-K
24 Oct, 2022 8-K
11 Oct, 2022 8-K
28 Sep, 2022 8-K
27 Sep, 2022 8-K
13 Sep, 2022 8-K
8 Sep, 2022 4
7 Sep, 2022 424B5
7 Sep, 2022 8-K
31 Aug, 2022 8-K
24 Aug, 2022 8-K
17 Aug, 2022 4
10 Aug, 2022 8-K
8 Aug, 2022 4
3 Aug, 2022 8-K
2 Aug, 2022 8-K
2 Aug, 2022 10-Q
19 Jul, 2022 8-K CEO Change
15 Jul, 2022 8-K
11 Jul, 2022 8-K
24 Jun, 2022 4
24 Jun, 2022 4
24 Jun, 2022 4
24 Jun, 2022 4
24 Jun, 2022 8-K
24 Jun, 2022 4
16 Jun, 2022 8-K
15 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
10 Jun, 2022 4
8 Jun, 2022 8-K
8 Jun, 2022 424B5
23 May, 2022 DEFA14A
17 May, 2022 8-K
17 May, 2022 8-K CEO Change
4 May, 2022 8-K
4 May, 2022 10-Q
3 May, 2022 8-K
29 Apr, 2022 DEF 14A
29 Apr, 2022 DEFA14A
13 Apr, 2022 8-K
13 Apr, 2022 424B5
14 Mar, 2022 4
14 Mar, 2022 4
14 Mar, 2022 4
14 Mar, 2022 4
14 Mar, 2022 4
14 Mar, 2022 4
14 Mar, 2022 4
14 Mar, 2022 4
8 Mar, 2022 8-K
8 Mar, 2022 10-K
3 Mar, 2022 8-K
1 Mar, 2022 8-K
25 Feb, 2022 8-K
25 Feb, 2022 8-K
11 Feb, 2022 SC 13G/A
10 Jan, 2022 8-K
7 Jan, 2022 S-8
21 Dec, 2021 8-K
16 Dec, 2021 8-K
2 Nov, 2021 8-K
2 Nov, 2021 10-Q
25 Oct, 2021 8-K
8 Oct, 2021 8-K
6 Oct, 2021 8-K
22 Sep, 2021 CT ORDER
13 Sep, 2021 8-K
27 Aug, 2021 4
9 Aug, 2021 8-K
3 Aug, 2021 10-Q
3 Aug, 2021 8-K
30 Jul, 2021 8-K
21 Jul, 2021 8-K
24 Jun, 2021 8-K
21 Jun, 2021 4
21 Jun, 2021 8-K
21 Jun, 2021 8-K
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
1 Jun, 2021 4
5 May, 2021 DEFA14A
5 May, 2021 DEF 14A
4 May, 2021 8-K
4 May, 2021 10-Q
5 Apr, 2021 EFFECT
1 Apr, 2021 CORRESP
31 Mar, 2021 UPLOAD
26 Mar, 2021 S-3
26 Mar, 2021 424B5
26 Mar, 2021 8-K
25 Mar, 2021 8-K
16 Mar, 2021 4
16 Mar, 2021 4
15 Mar, 2021 4
15 Mar, 2021 4
15 Mar, 2021 4
15 Mar, 2021 4
15 Mar, 2021 4
15 Mar, 2021 4
15 Mar, 2021 4
15 Mar, 2021 4
15 Mar, 2021 4
15 Mar, 2021 4
9 Mar, 2021 10-K
9 Mar, 2021 8-K
25 Feb, 2021 8-K
22 Feb, 2021 3
19 Feb, 2021 3
16 Feb, 2021 SC 13G/A
10 Feb, 2021 4
9 Feb, 2021 8-K
9 Feb, 2021 4
9 Feb, 2021 SC 13G/A
21 Jan, 2021 424B5
21 Jan, 2021 8-K
19 Jan, 2021 EFFECT
14 Jan, 2021 CORRESP
13 Jan, 2021 UPLOAD
8 Jan, 2021 S-8
8 Jan, 2021 8-K
8 Jan, 2021 S-3
8 Jan, 2021 3
7 Jan, 2021 8-K
4 Jan, 2021 4
Last update:2025-03-06 12:52:34.754967
Aquestive Therapeutics, Inc. by TradingView

Sign Up to Subscribe